This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
HMS Holdings' (HMSY) Q4 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Strong performance in Analytical Services drove HMS Holdings' (HMSY) performance in Q4.
With Equities on a Roll in 2019, a Quiet Week Leads to More Gains
by David Borun
The rally rolls on during a holiday-shortened week
HMS Holdings (HMSY) Q4 Earnings Surpass Estimates
by Zacks Equity Research
HMS Holdings (HMSY) delivered earnings and revenue surprises of 24.00% and -0.20%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
HMS Holdings (HMSY) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
HMS Holdings (HMSY) expects to gain from its total population management or TPM business in fourth-quarter 2018.
HMS Holdings (HMSY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
HMS Holdings (HMSY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Has HMS Holdings (HMSY) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (HMSY) Outperforming Other Medical Stocks This Year?
Third Straight Week of Gains to Start 2019
by David Borun
Positive sentiment erases 2018's losses.
CPSI vs. HMSY: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CPSI vs. HMSY: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights: Computer Programs and Systems, BioTelemetry, HMS, Amedisys and Molina Healthcare
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Computer Programs and Systems, BioTelemetry, HMS, Amedisys and Molina Healthcare
5 Great Healthcare Stocks to Buy for 2019
by Swarup Gupta
Rapid innovation, major advances and an ageing population have managed to sustain the popularity of healthcare stocks.
5 Secret Santa ETFs & Stocks to Buy for Christmas
by Sweta Killa
While most of the stocks and ETFs have been plunging over the past one month, there are some hidden gems or Secret Santa as we call them that could surprise investors with big returns this Christmas.
Healthcare Battered By Texas ACA Ruling
by Zacks Equity Research
Healthcare Battered By Texas ACA Ruling
Healthcare Stocks Take a Hit on Texas ACA Ruling
by Mark Vickery
Throwing out ACA as healthcare law in the U.S. would create plenty of tremors within the healthcare industry -- to say nothing of Insurance, Pharmaceuticals and related business sectors.
Near-Term Outlook for Medical Information Systems Industry
by Zacks Equity Research
The wave of digital transition is helping companies in the Zacks Medical Info Systems industry to create opportunities for investors.
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FYC
Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FYC
HMS Holdings (HMSY) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
HMS Holdings (HMSY) delivered earnings and revenue surprises of 47.62% and 8.16%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
HMS Holdings (HMSY) Q3 Earnings Preview: Here's What to Look Out For
by Zacks Equity Research
HMS Holdings (HMSY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Veeva's Technology Partner Joins Verix to Boost CRM Platform
by Zacks Equity Research
Veeva Systems' (VEEV) focus on cloud-based services is likely to favor the stock.
4 MedTech Stocks to Counter Mounting US-China Trade Tensions
by Sweta Jaiswal
In the wake of the impact of the U.S.-China trade war on the MedTech space, we have doubled down on some stocks which offer a safe haven to investors.
Cyber Attack Fears Grip MedTech: 3 Safe Stocks
by Sweta Jaiswal
In the wake of rising incidences of cyber attacks in the MedTech space, we have zeroed down on some stocks which at present are safe-havens for investors.
3 Cloud-Powered MedTech Stocks to Buy Right Now
by Nabaparna Bhattacharya
Here we take a look at three MedTech companies that are likely to make big business banking on cloud technologies.
Has HMS Holdings (HMSY) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (HMSY) Outperforming Other Medical Stocks This Year?
HMS Holdings (HMSY) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HMS Holdings (HMSY) delivered earnings and revenue surprises of 31.58% and 6.31%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Why HMS Holdings (HMSY) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
HMS Holdings (HMSY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.